What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Tooru Shimosegawa focuses on Internal medicine, Pancreatitis, Autoimmune pancreatitis, Gastroenterology and Pancreatic cancer.
His studies in Internal medicine integrate themes in fields like Endocrinology and Surgery.
The various areas that Tooru Shimosegawa examines in his Pancreatitis study include Abdominal pain, Disease, Acute pancreatitis and Intensive care medicine.
His study with Autoimmune pancreatitis involves better knowledge in Pathology.
His work carried out in the field of Gastroenterology brings together such families of science as Esophagus, Heartburn and Reflux esophagitis.
His Pancreatic cancer research includes themes of Cancer research, Gene knockdown, Pancreas and Adenocarcinoma.
His most cited work include:
- International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. (918 citations)
- Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy (532 citations)
- Standard steroid treatment for autoimmune pancreatitis (501 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Gastroenterology, Pancreatitis, Pathology and Cancer research.
He combines subjects such as Endocrinology and Oncology with his study of Internal medicine.
His Gastroenterology research includes elements of Esophagus, Secretion and Reflux esophagitis.
His studies deal with areas such as Pancreatic disease, Acute pancreatitis and Intensive care medicine as well as Pancreatitis.
Tooru Shimosegawa has included themes like Cancer cell, Cancer, Pancreatic cancer and Hepatic stellate cell in his Cancer research study.
His work deals with themes such as Surgical oncology and Abdominal surgery, which intersect with Hepatology.
He most often published in these fields:
- Internal medicine (44.76%)
- Gastroenterology (25.85%)
- Pancreatitis (18.70%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (44.76%)
- Gastroenterology (25.85%)
- Pancreatitis (18.70%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Pancreatitis, Surgery and Disease.
Tooru Shimosegawa frequently studies issues relating to Endocrinology and Internal medicine.
His research on Gastroenterology also deals with topics like
- Reflux that connect with fields like Proton-pump inhibitor,
- Biopsy that intertwine with fields like Fibrosis.
His Pancreatitis research is multidisciplinary, incorporating perspectives in Epidemiology, Pancreatic cancer, Diabetes mellitus, Pancreas and Evidence-based medicine.
His research in Pancreatic cancer intersects with topics in Cancer research, Hereditary pancreatitis, Hepatic stellate cell, Pancreaticoduodenectomy and Gemcitabine.
Within one scientific family, he focuses on topics pertaining to Early Gastric Cancer under Surgery, and may sometimes address concerns connected to Radical surgery and Surgical oncology.
Between 2017 and 2021, his most popular works were:
- Evidence-based clinical practice guidelines for inflammatory bowel disease (160 citations)
- International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club. (61 citations)
- Clinical practice guidelines for IgG4-related sclerosing cholangitis. (45 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His primary areas of study are Internal medicine, Pancreatitis, Disease, Gastroenterology and Pancreatic cancer.
Internal medicine and Endocrinology are frequently intertwined in his study.
His study in Pancreatitis is interdisciplinary in nature, drawing from both Exome sequencing, Odds ratio, Homeostasis, Diabetes mellitus and Pancreatectomy.
His Disease study combines topics from a wide range of disciplines, such as Genotyping, Allele, Etiology and Intensive care medicine.
His Gastroenterology study incorporates themes from Adverse effect, Retrospective cohort study and Cohort.
Tooru Shimosegawa has researched Pancreatic cancer in several fields, including Cancer research, Protein kinase B, Epidemiology, Hepatic stellate cell and Autoimmune pancreatitis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
